Parkinson’s disease
Amish aid study of Parkinson genetics
Nov. 11, 2013—Amish populations are valuable for genetic research because of their isolation, shared ancestry and homogeneous lifestyles.
Newsmakers: Vanderbilt’s teaching, research and patient care efforts are making an impact
May. 6, 2013—These stories from the past year show how Vanderbilt is making an impact, on campus and in the world.
Fava beans’ impact on urine sodium
Apr. 29, 2013—Eating fava beans increases dopamine in blood and urine, but does not stimulate urinary sodium excretion.
Novel push-pull action clue to brain disorders
Mar. 21, 2013—Researchers at Vanderbilt University have discovered a new “push-pull” mechanism in the brain that one day could lead to new treatments for movement disorders such as Parkinson’s disease, as well as stress-related disorders and addiction.
VU, Bristol-Myers to collaborate on Parkinson’s therapies
Sep. 21, 2012—Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.
Parkinson’s therapy may impact language
Sep. 7, 2012—Deep brain stimulation used to treat Parkinson’s disease may impair some aspects of language processing, a recent study suggests.
Events honor early patients of novel Parkinson’s study
Aug. 23, 2012—Pioneers of Parkinson’s disease research are gathering at Vanderbilt University Medical Center today to celebrate the end of a study that was an important first step in the quest to find a way to slow the progression of the degenerative movement disorder.
Research team invited to present at NIH institute’s 10th anniversary technology showcase
Jul. 3, 2012—Vanderbilt University researchers were one of nine teams invited to participate in the National Institute of Biomedical Imaging and Bioengineering’s 10th anniversary technology showcase June 22 in Bethesda, Maryland. NIBIB is an institute within the National Institutes of Health.
Next My Health Chat to explore ‘Discoveries in Neuroscience’ May 16
May. 1, 2012—The May program for My Health Chat will be the fascinating field of neuroscience. Panelists will be Reid Thompson, chair of neurosurgery and director of the Vanderbilt Brain Tumor Center, and Jeff Conn, who directs the Vanderbilt Center for Neuroscience Drug Discovery. Topics will range from the latest innovative approaches in neurosurgery to the development...
Minds wide open: Neuroscience at Vanderbilt
Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.
Inside a Pred’s Coach’s Deep Brain Stimulation Surgery
Jan. 30, 2012—When the Nashville Predators take the ice—it’s all about strength, precision and teamwork. But when a beloved former coach with the Preds started feeling the harsh symptoms of Parkinson’s Disease—he turned to a team here at Vanderbilt. Coach Brent Peterson allowed VUCast’s Carole Bartoo and Mike Todd inside the operating room to witness his deep...
VUCast Newscast: Inside a Preds coach’s deep brain stimulation surgery
Jan. 27, 2012—This Week on VUCast, Vanderbilt’s weekly newscast highlighting research, experts, students, sports and everything Vanderbilt: · Inside A Preds coach’s deep brain stimulation surgery · How nicotine could impact memory · Why a research lab wants Vandy undergrads